In Brief
This article was originally published in The Tan Sheet
Executive Summary
Lithia mineral water pegged as new drug; FDA warns Parrillo on unverified CofAs; Takeda markets Tylenol in Japan; CSPI sues J&J/McNeil over Splenda health claims; Harkin reports on pending health care cuts; more news In Brief.
You may also be interested in...
In Brief
POM, agency grilled during appeal to FTC board; Swander buys Physicians Formula; FDA again warns about Reumofan; Parrillo warned on GMPs, response; Potential botulism prompts Protica recalls; more news In Brief.
Regulatory News In Brief
FDA warns homeopathic firm; FDA deems “no complaints” inadequate response; NAD questions urinary control claims; Refunds for Disney and Marvel vitamins; more regulatory news in brief.
Regulatory News In Brief
FDA warns homeopathic firm; FDA deems “no complaints” inadequate response; NAD questions urinary control claims; Refunds for Disney and Marvel vitamins; more regulatory news in brief.